Etiopatogeneza miazdzycy: rola procesu zapalnego

• Autorzy: Nowicka G

Warianty tytułu

EN

Pathogenesis of atherosclerosis: role of inflammation

• Języki publikacji: PL

Słowa kluczowe

PL

blaszki miazdzycowe; dysfunkcje srodblonka; choroby czlowieka; miazdzyca; nacieczenia lipidowe; pekniecia blaszki miazdzycowej; etiopatogeneza

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2005
• Tom: 32
• Numer: 3
• Opis fizyczny: s.245-253,rys.,tab.,bibliogr.

Twórcy

autor

Nowicka G

• Instytut Zywnosci i Zywienia, Warszawa

Bibliografia

• 1. Camejo G., Hurt-Camejo E., Wiklund O., Bondjers G.: Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis. Atherosclerosis 1998, 139, 205-22.
• 2. Cockeill G., Rye K., Gamble J., et al.: High density lipoproteins inhibit cytokine induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb.Vasc. Biol., 1995, 15, 1987-93
• 3. Crea E, Biasucci L., Buffon A.: Role of inflammation in the pathogenesis of unstable coronary artery disease. Am. J. Cardiol., 1997, 80, Suppl. 10-6E.
• 4. Cybulsky M., Jiyama K., Li H., et al.: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest., 2001, 107, 1255-62
• 5. Cyms T., et al.: Disruption of 12/15 lipoxygenase diminishes atherosclerosis in apo E deficient mice. J. Clin. Invest., 1999, 103, 1597- 1604.
• 6. De Catterina R., Libby P., Peng H., et al. Nitric oxide decreases cytokine-induced endothelial activation; nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest., 1995, 96, 60-8.
• 7. Gerszten R., Mach F., Sauty A., Rosenzweig A., Luster A.: Chemokines, leukocytes and atherosclerosis. J. Lab. Clin. Med., 2000, 136, 87-92.
• 8. Gimbrone M.A.: Vascular endothelium, hemodynamic forces, and atherogenesis. Am. J. Pathol., 1999, 155, 1-5.
• 9. Hansson G.: Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vase. Biol. 2001, 21, 1876-90.
• 10. Hansson G.K.: Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vase. Biol. 2001, 21, 1876-90.
• 11. Ivandic B., et al.: Role of group II secretory phospholipase A2 in atherosclerosis. Increased atherosclerosis and altered lipoproteins in transgenic mice expressing group II a phospholipase A2. Arterioscler. Thromb. Vase. Biol., 1999, 19, 1284-90.
• 12. Lange A., Lang E., Bielak F., et al.: Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler. Thromb. Vase. Biol., 2002, 22, 418-23.
• 13. Li H., Cybulsky M., Gimbrone M., Libby P.: An atherogenic diet rapidly induces VCAM-1, a cytokine regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 1993, 13, 197-204.
• 14. Libby P, Ridker P, Maseri A.: Inflammation and atherosclerosis. Circulation 2002, 105, 1135-43.
• 15. Libby P.: Changing concepts of atherogenesis. J. Intern. Med., 2000, 247, 349-58.
• 16. Lusis AJ. Atherosclerosis. Nature 2000, 407, 233-41.
• 17. Manolio T., Bild D.: Coronary calcium, race, and genes. Arterioscler. Thromb. Vase. Biol., 2002, 22, 359-60.
• 18. Marathe S., Kuriakose G., Williams K., Tabas I.: Sphingomyelinase, an enzyme implicated in atherosclerosis, is present in atherosclerotic lession and binds to specific components of the subendothelial extracellular matrix. Arterioscler. Thromb. Vase. Biol., 1999, 19, 2648-58.
• 19. Nogal T., Resnick N., Atkinson W., Dewey C., Gimbrone M.: Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J. Clin. Invest., 1994, 94, 885-91.
• 20. Nowicka G.: HDL-lipoproteiny o wysokiej gęstości. Teoria a praktyka kliniczna. Kardiol. Pol., 2002, 57, 150-4.
• 21. Nowicka G.: Współczesne spojrzenie na antyaterogenne działanie lipoprotein o wysokiej gęstości. Czynniki Ryzyka 1998, 4, 12-15.
• 22. Prescott S., Mclntyre T., Zimmerman G., Stafforini D.: Sol Sherry Lecture in Thrombosis: molecular events in acute inflammation. Arterioscler. Thromb. Vase. Biol., 2002, 22, 727-33.
• 23. Ross R.: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362, 801-9.
• 24. Subbanagounder G., et al.: Determinants of bioactivity of oxidized phospholipids. Arterioscler. Thromb. Vase. Biol., 2000, 20, 2248-54.
• 25. Terkeltaub R., Boisvert W., Curtiss L.: Chemokines and atherosclerosis. Curr. Opin. Lipidol.,
• 1998, 9, 397-405.
• 26. Tremoli E., Camera M., Toschi V., Colli S.: Tissue factor in atherosclerosis. Arteriosclerosis 1999, 144, 273-83.
• 27. Watson K.: Pathophysiology of coronary calcification. J. Cardiol. Risk 2000, 7, 93-7.
• 28. Winther M., van Dijk K., Havekes L., Hofker M.: Macrophage scavenger receptor closs A: a multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vase. Biol., 2000, 20, 290-7.